Update on World Health Organization HIV Drug Resistance Prevention and Assessment Strategy: 2004-2011

被引：46

作者：

Jordan, M. R. ^{[1
,2
]}

Bennett, D. E. ^{[3
]}

Wainberg, M. A.

Havlir, D. ^{[4
]}

Hammer, S. ^{[5
]}

Yang, C. ^{[3
]}

Morris, L. ^{[6
]}

Peeters, M. ^{[7
,8
]}

Wensing, A. M. ^{[9
]}

Parkin, N. ^{[10
]}

Nachega, J. B. ^{[11
,12
]}

Phillips, A. ^{[13
]}

De Luca, A. ^{[14
,15
]}

Geng, E. ^{[4
]}

Calmy, A. ^{[16
,20
]}

Raizes, E. ^{[3
]}

Sandstrom, P. ^{[17
]}

Archibald, C. P. ^{[17
]}

Perriens, J.

McClure, C. M.

Hong, S. Y. ^{[2
]}

McMahon, J. H. ^{[2
,18
]}

Dedes, N. ^{[19
]}

Sutherland, D. ^{[17
]}

Bertagnolio, S.

机构：

[1] World Hlth Org, Dept HIV, CH-1211 Geneva 27, Switzerland

[2] Tufts Univ, Sch Med, Boston, MA 02111 USA

[3] US Ctr Dis Control & Prevent, Atlanta, GA USA

[4] Univ Calif San Francisco, San Francisco, CA 94143 USA

[5] Columbia Univ, Med Ctr, New York, NY USA

[6] Natl Inst Communicable Dis, AIDS Virus Res Unit, Johannesburg, South Africa

[7] Inst Rech Dev, UMI 233 TransVIHMI, Montpellier, France

[8] Univ Montpellier I, F-34006 Montpellier, France

[9] Univ Med Ctr Utrecht, Utrecht, Netherlands

[10] Data First Consulting, Belmont, CA USA

[11] Univ Stellenbosch, Cape Town, South Africa

[12] Johns Hopkins Bloomberg, Sch Publ Hlth, Baltimore, MD USA

[13] UCL, London WC1E 6BT, England

[14] Univ Cattolica Sacro Cuore, Inst Clin Infect Dis, Rome, Italy

[15] Siena Univ Hosp, Div Infect Dis, Siena, Italy

[16] Univ Hosp Geneva, Geneva, Switzerland

[17] Publ Hlth Agcy Canada, Ottawa, ON, Canada

[18] Alfred Hosp, Melbourne, Vic, Australia

[19] Int Treatment Preparedness Coalit, Bangkok, Thailand

[20] Med Sans Frontiere Access Campaign, Geneva, Switzerland

来源：

CLINICAL INFECTIOUS DISEASES | 2012年 / 54卷

基金：

比尔及梅琳达.盖茨基金会; 美国国家卫生研究院;

关键词：

EARLY-WARNING INDICATORS; ANTIRETROVIRAL THERAPY; VIROLOGICAL FAILURE; GENERIC PROTOCOL; PREGNANT-WOMEN; SURVEILLANCE; INDIVIDUALS; ADHERENCE; CLINICS; PREDICTORS;

D O I：

10.1093/cid/cis206

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The HIV drug resistance (HIVDR) prevention and assessment strategy, developed by the World Health Organization (WHO) in partnership with HIVResNet, includes monitoring of HIVDR early warning indicators, surveys to assess acquired and transmitted HIVDR, and development of an accredited HIVDR genotyping laboratory network to support survey implementation in resource-limited settings. As of June 2011, 52 countries had implemented at least 1 element of the strategy, and 27 laboratories had been accredited. As access to antiretrovirals expands under the WHO/Joint United Nations Programme on HIV/AIDS Treatment 2.0 initiative, it is essential to strengthen HIVDR surveillance efforts in the face of increasing concern about HIVDR emergence and transmission.

引用

页码：S245 / S249

页数：5

共 50 条

[31] HIV drug resistance genotyping external quality assurance (EQA) for laboratories in the World Health Organization (WHO) ResNet during 2007-2009
Parkin, N. T.
Fitzgibbon, J.
Bremer, J.
Bertagnolio, S.
ANTIVIRAL THERAPY, 2009, 14 (04) : A162 - A162
[32] Surveillance of HIV Drug Resistance in Children Receiving Antiretroviral Therapy: A Pilot Study of the World Health Organization's Generic Protocol in Maputo, Mozambique
Vaz, P.
Augusto, O.
Bila, D.
Macassa, E.
Vubil, A.
Jani, I. V.
Pillon, R.
Sandstrom, P.
Sutherland, D.
Giaquinto, C.
Jordan, M. R.
Bertagnolio, S.
CLINICAL INFECTIOUS DISEASES, 2012, 54 : S369 - S374
[33] Discursive enactments of the World Health Organization’s policies: Competing cultural models in Tanzanian HIV/AIDS prevention
Christina Higgins
Language Policy, 2010, 9 : 65 - 85
[34] Discursive enactments of the World Health Organization's policies: Competing cultural models in Tanzanian HIV/AIDS prevention
Higgins, Christina
LANGUAGE POLICY, 2010, 9 (01) : 65 - 85
[35] The World Health Organization African region external quality assessment scheme for anti-HIV serology
Cham, Fatim
Maleka, Mahlatse
Masango, Martin
Goetsch, Emma
Belabbes, El H.
Singh, Beverley
Gershy-Damet, Guy M.
Puren, Adrian
AFRICAN JOURNAL OF LABORATORY MEDICINE, 2012, 1 (01)
[36] Validation of the Brazilian version of the World Health Organization Disability Assessment Schedule 2.0 for individuals with HIV/AIDS
Sousa Barbosa, Karolyne Stefanie
Sulyvan de Castro, Shamyr
Leite, Camila Ferreira
Nacci, Franciele Rodrigues
Accioly, Marilita Falangola
CIENCIA & SAUDE COLETIVA, 2020, 25 (03): : 837 - 844
[37] PSYCHOMETRIC ASSESSMENT OF URDU VERSION OF BRIEF HIV WORLD HEALTH ORGANIZATION QUALITY OF LIFE INSTRUMENT IN PAKISTANI HIV/AIDS PATIENTS
Ahmed, A.
Saqlain, M.
Dujaili, J.
VALUE IN HEALTH, 2020, 23 : S183 - S183
[38] New definitions of pre-extensively and extensively drug-resistant tuberculosis: update from the World Health Organization
Viney, Kerri
Linh, Nguyen Nhat
Gegia, Medea
Zignol, Matteo
Glaziou, Philippe
Ismail, Nazir
Kasaeva, Tereza
Mirzayev, Fuad
EUROPEAN RESPIRATORY JOURNAL, 2021, 57 (04)
[39] Dapivirine vaginal ring for HIV prevention: modelling health outcomes, drug resistance and cost-effectiveness
Glaubius, Robert
Ding, Yajun
Penrose, Kerri J.
Hood, Greg
Engquist, Erik
Mellors, John W.
Parikh, Urvi M.
Abbas, Ume L.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2019, 22 (05)
[40] Assessment of Drug Prescribing Pattern Using World Health Organization Indicators in a Tertiary Care Teaching Hospital
Hussain, Sartaj
Yadav, Suraj Singh
Sawlani, Kamal Kumar
Khattri, Sanjay
INDIAN JOURNAL OF PUBLIC HEALTH, 2018, 62 (02) : 156 - 158

← 1 2 3 4 5 →